Report Interpretation
Covering the latest research from top Wall Street investment banks
Report InterpretationHilo Research

Chinese AI accelerator companies Report Interpretation

The report highlights earnings, product-shipment and order catalysts for Cambricon, Hygon, Iluvatar and MetaX. Morgan Stanley sees potential for modest upside surprises while retaining an Attractive view on Greater China technology semiconductors.

InstitutionMorgan Stanley
Date20260812
IndustryGreater China Technology Semiconductors

Summary

The report highlights earnings, product-shipment and order catalysts for Cambricon, Hygon, Iluvatar and MetaX. Morgan Stanley sees potential for modest upside surprises while retaining an Attractive view on Greater China technology semiconductors.

Greater China Technology Semiconductors industry view: Attractive
AI acceleratorsChina semiconductorsearnings catalystsAI demandCSP orderslocalization
  • MetaX 2Q26 revenue is forecast at Rmb775mn, up 38% quarter-on-quarter and 30% year-on-year, with 59% gross margin.
  • Iluvatar's 1H26 revenue is forecast at Rmb976mn, up 201% year-on-year, with 49% gross margin.
  • Tencent's CPU-supply comments and Hygon's prepayments and inventory are key signals for server-CPU demand.
  • Cambricon's MLU690 shipment ramp is a high-importance 3Q26 catalyst.

Report Interpretation

Overview

Morgan Stanley’s catalyst preview examines near-term events that could affect the shares of four Chinese AI accelerator companies: Cambricon, Hygon, Iluvatar and MetaX. The report focuses on earnings delivery, shipment ramps, customer orders, supply conditions and AI-demand signals.

Core views

Morgan Stanley frames the report around near-term catalysts for key Chinese AI accelerator companies, with the sector carrying an Attractive industry view. The central premise is that earnings releases, new-product shipment ramps, customer-order developments and supply-chain signals can move share prices in the near term, particularly if they indicate stronger AI demand, faster localization or improving availability of domestic compute products. For Cambricon, the key 3Q26 catalyst is the ramp of MLU690 shipments, assessed as high importance with an in-line expected outcome. Morgan Stanley identifies stronger-than-expected AI demand, CSP order ramp-up and accelerating localization as potential upside factors. The report also flags capacity and yield constraints, customer concentration and slower technology iteration as downside risks. Its valuation assumptions include an 8.4% cost of equity, based on beta of 1.06, a 2.0% risk-free rate and a 6.0% equity risk premium; a 40% long-term payout ratio; 16% medium-term growth; and 6% terminal growth. For MetaX Integrated Circuits, Morgan Stanley expects its 2Q26 results on 30 August to be a very high-importance event with scope for a modest upside surprise. It forecasts revenue of Rmb775mn, up 38% quarter-on-quarter and 30% year-on-year, alongside a 59% gross margin. The report’s positive catalysts include faster CUDA migration, stronger government and CSP orders, and a better-than-expected C600 ramp. Product concentration, weaker-than-expected demand and intensifying competition are identified as risks. The valuation framework assumes a 6.5% cost of equity, beta of 0.75, a 2.0% risk-free rate, 6.5% equity risk premium, 51% target payout ratio, 18% medium-term CAGR through 2038e and 6% perpetual growth. For Iluvatar CoreX Semiconductor, the 1H26 earnings release on 28 August is considered very high importance and is expected to deliver a modest upside surprise. Morgan Stanley forecasts 1H26 revenue of Rmb976mn, up 201% year-on-year, with a 49% gross margin. It also highlights 3Q26 Tiangai 300 test results and order negotiations as a high-importance catalyst, with attention on specific order volumes and chip pricing. Stronger CSP orders, faster CUDA replacement through Iluvatar’s software, and expansion of domestic and overseas capacity are listed as positive drivers; order ramp below expectations and escalation of sanctions are downside risks. The valuation inputs include an 8.3% cost of equity, beta of 1.05, a 2.0% risk-free rate, 6.0% equity risk premium, 34% payout ratio, 16% medium-term growth and 6% terminal growth. For Hygon, Morgan Stanley focuses on Tencent’s 2Q26 results and the company’s 1H26 release. Tencent had said on its 1Q26 earnings call that it had secured a good supply of CPU chips, while Morgan Stanley’s supply-chain checks indicated increasing adoption of AMD, Nvidia and Hygon solutions. If Tencent signals tightening CPU supply, Morgan Stanley expects Hygon to benefit from tight server-CPU availability. Hygon’s preliminary results had already been released in mid-July, so the key focus for the 1H26 release is its prepayment and inventory trend; an increase could indicate shipment stability in 2027. Potential upside factors are stronger China AI demand, further differentiation and market-share gains in domestic CPU and GPU markets, and faster leading-node capacity ramp-up. Risks include local GPU price competition, weaker China AI demand, and slower yield improvement and capacity expansion at local leading-node foundries. Morgan Stanley’s valuation assumptions include an 8.0% cost of equity, beta of 1.05, a 2.0% risk-free rate, 5.8% risk premium, 50% payout ratio, 25.0% medium-term growth and 5.0% terminal growth.

Analysis framework

Morgan Stanley organizes the analysis by company and near-term catalyst, assessing event importance and likely surprise direction. It combines earnings forecasts, supply-chain checks, management commentary, product-ramp and order indicators, and company-specific valuation assumptions.

Methodology notes

  • Industry AnalysisSupply-demand framework

    AI accelerator demand, chip supply, capacity, yields and customer orders

    The report links AI demand, CPU supply tightness, foundry capacity and customer order ramps to expected shipment and earnings outcomes.

  • Valuation methodsDDM (Dividend Discount Model)

    Valuation assumptions using cost of equity, payout ratios and terminal growth

    The stated cost of equity, payout and growth assumptions are inputs to a dividend-based valuation framework for the covered companies.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • Cambricon Technology Corporation (688256.SS)
    Covered AI accelerator company; MLU690 shipment ramp is the key 3Q26 catalyst.
    Strengths
    Potential stronger AI demand, CSP order ramp and accelerating localization.
    Weaknesses
    Capacity and yield constraints; customer concentration; slower technology iteration.
    Comparison
    Competes with local CPU and GPU providers.
    Risks
    Capacity and yield constraints, customer concentration and slower technology iteration.
  • Hygon Information Technology Co., Ltd. (688041.SS)
    Covered server CPU and GPU company linked to potential CPU-supply tightness.
    Strengths
    Potential differentiation, market-share gains and benefit from tighter server-CPU supply.
    Weaknesses
    Exposure to local GPU price competition and foundry yield or capacity delays.
    Comparison
    Supply-chain checks show adoption alongside AMD and Nvidia solutions.
    Risks
    Weaker China AI demand, pricing competition and slower leading-node capacity buildout.
  • Iluvatar CoreX Semiconductor Co., Ltd. (9903.HK)
    Covered AI accelerator company with earnings and Tiangai 300 order catalysts.
    Strengths
    Potential CSP orders, CUDA replacement through its software and capacity expansion.
    Weaknesses
    Order execution is material to the thesis.
    Risks
    Order ramp below expectations and escalation of sanctions.
  • MetaX Integrated Circuits (688802.SS)
    Covered AI accelerator company with a 2Q26 earnings catalyst.
    Strengths
    Potential CUDA migration, government and CSP orders, and C600 ramp.
    Weaknesses
    Product concentration and competitive exposure.
    Risks
    Weaker-than-expected demand and intensifying competition.

Key data

  • MetaX 2Q26 revenue forecastRmb775mnUp 38% Q/Q and 30% Y/Y; forecast gross margin of 59%.
  • Iluvatar 1H26 revenue forecastRmb976mnUp 201% Y/Y; forecast gross margin of 49%.
  • Cambricon catalystMLU690 shipments in 3Q26High importance; expected in-line.
  • MetaX earnings catalyst30 Aug 2026Very high importance; modest upside surprise expected.
  • Iluvatar earnings catalyst28 Aug 2026Very high importance; modest upside surprise expected.

Impact & implications

The report indicates that evidence of stronger AI demand, CSP and government order growth, successful product ramps, CUDA replacement and localization could support the companies discussed. Conversely, supply constraints, weak orders, competition, technology delays and sanctions could undermine the expected outcomes.

Risks

  • China AI demand could be weaker than expected.
  • Local GPU pricing competition could intensify.
  • Capacity, yield and leading-node foundry buildout could progress more slowly than expected.
  • Customer or product concentration could increase company-specific exposure.
  • Order ramps may fall below expectations, and sanctions could escalate.

What to watch

  • Cambricon’s MLU690 shipment ramp during 3Q26.
  • MetaX’s 2Q26 results on 30 August, including revenue and gross margin.
  • Iluvatar’s 1H26 results on 28 August and Tiangai 300 test results, orders, volumes and pricing in 3Q26.
  • Tencent’s comments on CPU-chip supply and Hygon’s prepayment and inventory trends.
  • CSP orders, CUDA migration or replacement progress, and domestic leading-node capacity and yield developments.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins